Education
About Us
Working with TipRanks
Follow Us
Bliss Gvs Pharma Limited (IN:BLISSGVS)
:BLISSGVS
Total Valuation
Bliss Gvs Pharma Limited has a market cap or net worth of ₹18.74B. The enterprise value is ₹11.76B.
Market Cap₹18.74B
Enterprise Value₹11.76B
Share Statistics
Bliss Gvs Pharma Limited has 105,497,520 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding105,497,520
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bliss Gvs Pharma Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 17.22%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)17.22%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee9.74M
Profits Per Employee1.01M
Employee Count831
Asset Turnover0.62
Inventory Turnover3.29
Valuation Ratios
The current PE Ratio of Bliss Gvs Pharma Limited is 17.5. Bliss Gvs Pharma Limited’s PEG ratio is 1.37.
PE Ratio17.5
PS Ratio1.56
PB Ratio1.20
Price to Fair Value1.20
Price to FCF42.37
Price to Operating Cash Flow0.00
PEG Ratio1.37
Income Statement
In the last 12 months, Bliss Gvs Pharma Limited had revenue of 8.10B and earned 842.99M in profits. Earnings per share was 8.02.
Revenue8.10B
Gross Profit3.96B
Operating Income2.84B
Pretax Income1.26B
Net Income842.99M
EBITDA1.27B
Earnings Per Share (EPS)8.02
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Bliss Gvs Pharma Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.29%
Dividend Per Share₹0.5
Dividend Yield0.29%
Payout Ratio4.94%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.47
52-Week Price Change58.35%
50-Day Moving Average154.10
200-Day Moving Average141.12
Relative Strength Index (RSI)63.53
Average Volume (3m)110.18K
Important Dates
Bliss Gvs Pharma Limited upcoming earnings date is Oct 24, 2025, TBA (Confirmed).
Last Earnings DateJul 29, 2025
Next Earnings DateOct 24, 2025
Ex-Dividend DateJul 24, 2025
Financial Position
Bliss Gvs Pharma Limited as a current ratio of 4.81, with Debt / Equity ratio of 8.39%
Current Ratio4.81
Quick Ratio4.08
Debt to Market Cap0.06
Net Debt to EBITDA-0.99
Interest Coverage Ratio34.97
Taxes
In the past 12 months, Bliss Gvs Pharma Limited has paid 353.84M in taxes.
Income Tax353.84M
Effective Tax Rate0.28
Enterprise Valuation
Bliss Gvs Pharma Limited EV to EBITDA ratio is 8.99, with an EV/FCF ratio of 38.18.
EV to Sales1.41
EV to EBITDA8.99
EV to Free Cash Flow38.18
EV to Operating Cash Flow10.76
Balance Sheet
Bliss Gvs Pharma Limited has ₹2.13B in cash and marketable securities with ₹881.04M in debt, giving a net cash position of -₹1.25B billion.
Cash & Marketable Securities₹2.13B
Total Debt₹881.04M
Net Cash-₹1.25B
Net Cash Per Share-₹11.87
Tangible Book Value Per Share₹102.22
Margins
Gross margin is 45.42%, with operating margin of 35.07%, and net profit margin of 10.41%.
Gross Margin45.42%
Operating Margin35.07%
Pretax Margin15.52%
Net Profit Margin10.41%
EBITDA Margin15.65%
EBIT Margin12.01%
Analyst Forecast
The average price target for Bliss Gvs Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast4.93%
EPS Growth Forecast29.92%